MarkTomislavOstermanMD
Gastroenterology • Chesterbrook, PAAdvanced Endoscopic Interventional, Inflammatory Bowel Disease
Associate Professor, Medicine, Perelman School of Medicine
Dr. Osterman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
250 King of Prussia Rd
Chesterbrook, PA 19087Phone+1 800-789-7366Fax+1 610-902-1544- Is this information wrong?
Education & Training
University of Pennsylvania Health SystemFellowship, Gastroenterology, 2002 - 2005
Brigham and Women's HospitalResidency, Internal Medicine, 1999 - 2002
Harvard Medical SchoolClass of 1999
Certifications & Licensure
PA State Medical License 2003 - 2024
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Study of Cimzia for the Treatment of Ulcerative Colitis Start of enrollment: 2010 Dec 01
- Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis Start of enrollment: 2012 Feb 01
- Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease Start of enrollment: 2014 Feb 01
Publications & Presentations
PubMed
- ENTERPRET: A Randomized Controlled Trial of Vedolizumab Dose Optimization in Patients With Ulcerative Colitis Who Have Early Nonresponse.Vipul Jairath, Andres Yarur, Mark T Osterman, Alexandra James, Diane Balma, Shailly Mehrotra, Lili Yang, Vijay Yajnik, Rana M Qasim Khan> ;Clinical Gastroenterology and Hepatology. 2023 Nov 10
- 10 citationsReal-world multicentre observational study including population pharmacokinetic modelling to evaluate the exposure-response relationship of vedolizumab in inflammatory...Niels Vande Casteele, William J Sandborn, Brian G Feagan, Séverine Vermeire, Parambir S Dulai, Andres Yarur, Xavier Roblin, Shomron Ben-Horin, Iris Dotan, Mark T Oster...> ;Alimentary Pharmacology & Therapeutics. 2022 Aug 1
- 1 citationsAssociation Between Vedolizumab Levels, Anti-vedolizumab Antibodies, and Endoscopic Healing Index in a Large Population of Patients with Inflammatory Bowel DiseasesAndres Yarur, Parakkal Deepak, Niels Vande Casteele, Robert Battat, Anjali Jain, Lauren Okada, Mark T. Osterman, Miguel Regueiro> ;Digestive Diseases and Sciences. 2021 Oct 1
- Join now to see all
Press Mentions
Corrigendum: 2016 ACG Abstracts-Inflammatory Bowel DiseaseJanuary 10th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
